Literature DB >> 863804

Antibacterial activity of clindamycin and lincomycin in human bone.

K Dornbusch, A Carlström, H Hugo, A Lidström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 863804     DOI： 10.1093/jac/3.2.153

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.

Authors:  Emmanuel Curis; Vincent Pestre; Vincent Jullien; Luc Eyrolle; Denis Archambeau; Philippe Morand; Laure Gatin; Matthieu Karoubi; Nicolas Pinar; Valérie Dumaine; Jean-Claude Nguyen Van; Antoine Babinet; Philippe Anract; Dominique Salmon
Journal:  Infection       Date:  2015-04-03       Impact factor: 3.553

2.  Penetration of methicillin, oxacillin, and cephalothin into bone and synovial tissues.

Authors:  R H Fitzgerald; P J Kelly; R J Snyder; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

3.  Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.

Authors:  J T Mader; K Adams; L Morrison
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

4.  Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Authors:  Naïm Bouazza; Vincent Pestre; Vincent Jullien; Emmanuel Curis; Saïk Urien; Dominique Salmon; Jean-Marc Tréluyer
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 5.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

6.  Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.

Authors:  Valérie Zeller; Arnaud Dzeing-Ella; Marie-Dominique Kitzis; Jean-Marc Ziza; Patrick Mamoudy; Nicole Desplaces
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

7.  Penetration into bone and tissues of clindamycin phosphate.

Authors:  P Baird; S Hughes; M Sullivan; I Willmot
Journal:  Postgrad Med J       Date:  1978-02       Impact factor: 2.401

8.  Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults.

Authors:  S Esposito; S Leone; M Bassetti; S Borrè; F Leoncini; E Meani; M Venditti; F Mazzotta
Journal:  Infection       Date:  2009-11-10       Impact factor: 7.455
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.